ProMIS Neurosciences, Inc.
PMN
$0.5359
-$0.0131-2.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 60.13% | 26.35% | |||
| Gross Profit | -60.13% | -26.35% | |||
| SG&A Expenses | -28.10% | 209.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 36.52% | 198.12% | |||
| Operating Income | -36.52% | -198.12% | |||
| Income Before Tax | -37.69% | -2,984.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -37.69% | -2,984.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -37.69% | -2,984.76% | |||
| EBIT | -36.52% | -198.12% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -37.71% | -3,000.00% | |||
| Normalized Basic EPS | -37.63% | -325.30% | |||
| EPS Diluted | -37.71% | -3,000.00% | |||
| Normalized Diluted EPS | -37.63% | -325.30% | |||
| Average Basic Shares Outstanding | 0.00% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||